Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cornelia Liedtke"'
Autor:
Oleg Gluz, Ulrike Nitz, Cornelia Liedtke, Matthias Christgen, Eva-Maria Grischke, Helmut Forstbauer, Michael Braun, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Claudia Schumacher, Nikola Bangemann, Christoph Lindner, Sherko Kuemmel, Michael Clemens, Jochem Potenberg, Peter Staib, Andreas Kohls, Raquel von Schumann, Ronald Kates, Johannes Schumacher, Rachel Wuerstlein, Hans Heinrich Kreipe, Nadia Harbeck
Pathological complete response (pCR) is associated with improved prognosis in triple-negative breast cancer (TNBC). The optimal chemotherapy regimen is unclear. Weekly nab-paclitaxel vs conventional paclitaxel or addition of carboplatin to anthracycl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590677f09768f30013068e57eb5b3aae
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85053498560
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85053498560
Publikováno v:
Lancet (London, England). 389(10087)
Summary Triple-negative breast cancer is a heterogeneous disease and specific therapies have not been available for a long time. Therefore, conventional chemotherapy is still considered the clinical state of the art. Different subgroups of triple-neg
Autor:
Cornelia Liedtke, Erich-Franz Solomayer, Maria Karsten, Julia Caroline Radosa, Melissa Pilewskie, Michelle Stempel, Tari A. King, Anne Eaton, Monica Morrow, Amrin Khander
Publikováno v:
Annals of surgical oncology. 24(3)
Triple-negative breast cancer (TNBC) subtype and young patient age are both associated with an increased risk of local recurrence (LR) and distant recurrence (DR). In young women with TNBC, it is unclear whether subtype or patient age is driving prog
Autor:
Achim Rody, Cornelia Liedtke
Publikováno v:
Reviews on recent clinical trials. 12(2)
Patients with triple negative breast cancer (TNBC) are characterized by an unfavorable prognosis particularly when not responding well to anthracycline-taxane chemotherapy. This is due to a more aggressive biology in some cases but most importantly t
Autor:
Elmar Stickeler, Achim Rody, Erich-Franz Solomayer, Manuela Abel, Eberhard Müller, Gilda Schmidt, Christoph Gerlinger, Jan Endrikat, Rainer M. Bohle, Theresa Link, Pauline Wimberger, Stefan Stein, Ingolf Juhasz-Böss, Cornelia Liedtke, Tanja Fehm
Publikováno v:
Journal of cancer research and clinical oncology. 142(6)
Triple-negative breast cancer (TNBC) is characterized by a strong heterogeneity with regard to tumour biology as well as in the clinical course of the disease. This study aimed to analyse whether there are any prognostic factors enabling prediction o